Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine

Abroad (travel likely)Recruiting

Conditions

Herpes Zoster

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Jiangsu Provincial Center for Diseases Control and Prevention (Jiangsu Provincial Academy of Preventive Medicine), Nanjing, Jiangsu, China
Contact: Study coordinator (Pengfei Jin) · jpf19891103@163.com · #86-25-83759913

Study leads

Pengfei Jin
Principal Investigator
Jiangsu Provincial Center for Diseases Control and Prevention (Jiangsu Provincial Academy of Preventive Medicine)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland

Herpes Zoster

Abroad (travel likely)RecruitingPHASE4

Espoo, Finland · Helsinki, Finland

Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older

Herpes Zoster (HZ)

Abroad (travel likely)RecruitingPHASE1

Meizhou, China

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

Herpes Zoster

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

Subcutaneous Calcitonin in Acute Herpes Zoster

Calcitonin · Subcutaneous · Acute Herpes Zoster

Abroad (travel likely)RecruitingPHASE3

Tanta, Egypt